Cargando…

Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9

[Image: see text] Cytochrome P450 enzymes (P450s) are important in drug metabolism and have been linked to adverse drug reactions. P450s display broad substrate reactivity, and prediction of metabolites is complex. QM/MM studies of P450 reactivity have provided insight into important details of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lonsdale, Richard, Houghton, Kerensa T., Żurek, Jolanta, Bathelt, Christine M., Foloppe, Nicolas, de Groot, Marcel J., Harvey, Jeremy N., Mulholland, Adrian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670427/
https://www.ncbi.nlm.nih.gov/pubmed/23641937
http://dx.doi.org/10.1021/ja402016p
_version_ 1782271843206430720
author Lonsdale, Richard
Houghton, Kerensa T.
Żurek, Jolanta
Bathelt, Christine M.
Foloppe, Nicolas
de Groot, Marcel J.
Harvey, Jeremy N.
Mulholland, Adrian J.
author_facet Lonsdale, Richard
Houghton, Kerensa T.
Żurek, Jolanta
Bathelt, Christine M.
Foloppe, Nicolas
de Groot, Marcel J.
Harvey, Jeremy N.
Mulholland, Adrian J.
author_sort Lonsdale, Richard
collection PubMed
description [Image: see text] Cytochrome P450 enzymes (P450s) are important in drug metabolism and have been linked to adverse drug reactions. P450s display broad substrate reactivity, and prediction of metabolites is complex. QM/MM studies of P450 reactivity have provided insight into important details of the reaction mechanisms and have the potential to make predictions of metabolite formation. Here we present a comprehensive study of the oxidation of three widely used pharmaceutical compounds (S-ibuprofen, diclofenac, and S-warfarin) by one of the major drug-metabolizing P450 isoforms, CYP2C9. The reaction barriers to substrate oxidation by the iron-oxo species (Compound I) have been calculated at the B3LYP-D/CHARMM27 level for different possible metabolism sites for each drug, on multiple pathways. In the cases of ibuprofen and warfarin, the process with the lowest activation energy is consistent with the experimentally preferred metabolite. For diclofenac, the pathway leading to the experimentally observed metabolite is not the one with the lowest activation energy. This apparent inconsistency with experiment might be explained by the two very different binding modes involved in oxidation at the two competing positions. The carboxylate of diclofenac interacts strongly with the CYP2C9 Arg108 side chain in the transition state for formation of the observed metabolite—but not in that for the competing pathway. We compare reaction barriers calculated both in the presence and in the absence of the protein and observe a marked improvement in selectivity prediction ability upon inclusion of the protein for all of the substrates studied. The barriers calculated with the protein are generally higher than those calculated in the gas phase. This suggests that active-site residues surrounding the substrate play an important role in controlling selectivity in CYP2C9. The results show that inclusion of sampling (particularly) and dispersion effects is important in making accurate predictions of drug metabolism selectivity of P450s using QM/MM methods.
format Online
Article
Text
id pubmed-3670427
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-36704272013-06-03 Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9 Lonsdale, Richard Houghton, Kerensa T. Żurek, Jolanta Bathelt, Christine M. Foloppe, Nicolas de Groot, Marcel J. Harvey, Jeremy N. Mulholland, Adrian J. J Am Chem Soc [Image: see text] Cytochrome P450 enzymes (P450s) are important in drug metabolism and have been linked to adverse drug reactions. P450s display broad substrate reactivity, and prediction of metabolites is complex. QM/MM studies of P450 reactivity have provided insight into important details of the reaction mechanisms and have the potential to make predictions of metabolite formation. Here we present a comprehensive study of the oxidation of three widely used pharmaceutical compounds (S-ibuprofen, diclofenac, and S-warfarin) by one of the major drug-metabolizing P450 isoforms, CYP2C9. The reaction barriers to substrate oxidation by the iron-oxo species (Compound I) have been calculated at the B3LYP-D/CHARMM27 level for different possible metabolism sites for each drug, on multiple pathways. In the cases of ibuprofen and warfarin, the process with the lowest activation energy is consistent with the experimentally preferred metabolite. For diclofenac, the pathway leading to the experimentally observed metabolite is not the one with the lowest activation energy. This apparent inconsistency with experiment might be explained by the two very different binding modes involved in oxidation at the two competing positions. The carboxylate of diclofenac interacts strongly with the CYP2C9 Arg108 side chain in the transition state for formation of the observed metabolite—but not in that for the competing pathway. We compare reaction barriers calculated both in the presence and in the absence of the protein and observe a marked improvement in selectivity prediction ability upon inclusion of the protein for all of the substrates studied. The barriers calculated with the protein are generally higher than those calculated in the gas phase. This suggests that active-site residues surrounding the substrate play an important role in controlling selectivity in CYP2C9. The results show that inclusion of sampling (particularly) and dispersion effects is important in making accurate predictions of drug metabolism selectivity of P450s using QM/MM methods. American Chemical Society 2013-05-03 2013-05-29 /pmc/articles/PMC3670427/ /pubmed/23641937 http://dx.doi.org/10.1021/ja402016p Text en Copyright © 2013 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html)
spellingShingle Lonsdale, Richard
Houghton, Kerensa T.
Żurek, Jolanta
Bathelt, Christine M.
Foloppe, Nicolas
de Groot, Marcel J.
Harvey, Jeremy N.
Mulholland, Adrian J.
Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9
title Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9
title_full Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9
title_fullStr Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9
title_full_unstemmed Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9
title_short Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9
title_sort quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome p450 2c9
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670427/
https://www.ncbi.nlm.nih.gov/pubmed/23641937
http://dx.doi.org/10.1021/ja402016p
work_keys_str_mv AT lonsdalerichard quantummechanicsmolecularmechanicsmodelingofregioselectivityofdrugmetabolismincytochromep4502c9
AT houghtonkerensat quantummechanicsmolecularmechanicsmodelingofregioselectivityofdrugmetabolismincytochromep4502c9
AT zurekjolanta quantummechanicsmolecularmechanicsmodelingofregioselectivityofdrugmetabolismincytochromep4502c9
AT batheltchristinem quantummechanicsmolecularmechanicsmodelingofregioselectivityofdrugmetabolismincytochromep4502c9
AT foloppenicolas quantummechanicsmolecularmechanicsmodelingofregioselectivityofdrugmetabolismincytochromep4502c9
AT degrootmarcelj quantummechanicsmolecularmechanicsmodelingofregioselectivityofdrugmetabolismincytochromep4502c9
AT harveyjeremyn quantummechanicsmolecularmechanicsmodelingofregioselectivityofdrugmetabolismincytochromep4502c9
AT mulhollandadrianj quantummechanicsmolecularmechanicsmodelingofregioselectivityofdrugmetabolismincytochromep4502c9